(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -51.29%1.59B | -42.04%1.73B | 5.13%2.92B | 8.18%2.96B | 30.52%3.26B | -9.05%2.98B | -1.12%2.78B | 0.05%2.74B | 9.20%2.5B | 26.01%3.28B |
Transactional financial assets | --934.61M | --839.11M | --626.8M | --652.11M | ---- | ---- | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | 128.91%29.36M | 422.73%36.9M | 65.07%23.18M | 30.44%9.39M | 6.38%12.83M | -97.42%7.06M | -95.03%14.04M | -96.80%7.2M | -93.68%12.06M | 15.60%273.72M |
-Accounts receivable | 128.91%29.36M | 422.73%36.9M | 65.07%23.18M | 30.44%9.39M | 6.38%12.83M | -97.42%7.06M | -95.03%14.04M | -96.80%7.2M | -93.68%12.06M | 15.60%273.72M |
Other receivables (including interest and dividends) | -33.96%39.59M | -62.90%29.54M | -39.86%23.41M | 28.89%16.38M | -26.90%59.95M | 137.77%79.61M | -14.17%38.92M | -32.29%12.71M | 105.83%82.01M | 305.86%33.48M |
-Other receivable | ---- | -62.90%29.54M | ---- | ---- | ---- | 137.77%79.61M | ---- | -32.29%12.71M | ---- | 305.86%33.48M |
Advance payment | -42.02%58.52M | 47.74%121.61M | -46.21%79.59M | 41.43%25.56M | -18.40%100.93M | -45.07%82.31M | 26.83%147.96M | -25.61%18.07M | 28.70%123.69M | 70.62%149.85M |
Inventories | -42.13%326.92M | -17.42%424.87M | -10.49%383.21M | 2.49%419.22M | 26.83%564.9M | 13.47%514.48M | -40.31%428.14M | -31.45%409.03M | -52.23%445.39M | -1.34%453.42M |
Other current assets | -45.06%6.87M | 6.27%10M | -62.10%7.89M | -74.49%6.71M | -47.61%12.5M | -52.50%9.41M | 0.31%20.82M | 11.98%26.3M | -18.46%23.86M | -15.76%19.8M |
Total current assets | -25.63%2.99B | -13.20%3.19B | 18.56%4.07B | 27.40%4.09B | 25.95%4.01B | -12.69%3.68B | -14.13%3.43B | -11.41%3.21B | -10.92%3.19B | 23.14%4.21B |
Non Current assets | ||||||||||
Other non-current financial assets | 0.17%1.1B | 0.17%1.1B | 0.17%1.1B | 0.17%1.1B | 4.91%1.1B | --1.1B | --1.1B | --1.1B | --1.05B | ---- |
Investment real estate | 0.01%454.1M | 0.01%454.1M | 0.01%454.1M | 0.01%454.1M | 14.70%454.05M | 14.70%454.05M | 14.70%454.05M | 14.70%454.05M | 62.46%395.86M | 61.14%395.86M |
Long-term equity investment | 3.47%79.12M | 4.70%79.1M | 1.49%76.49M | 1.92%76.64M | 27.55%76.47M | 48.23%75.55M | 47.48%75.37M | 47.29%75.19M | 16.91%59.95M | -0.57%50.97M |
Fixed assets | ---- | 11.39%331.56M | ---- | ---- | ---- | 60.42%297.64M | ---- | 54.56%305.22M | ---- | 17.01%185.54M |
Fixed assets liquidation | ---- | 0.00%999.82K | ---- | ---- | ---- | 0.00%999.82K | ---- | 0.00%999.82K | ---- | 0.00%999.82K |
Constru in process | ---- | 55.35%685.88M | ---- | ---- | ---- | 79.86%441.51M | ---- | 62.47%313.18M | ---- | 137.40%245.48M |
Construction materials | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Productive biological assets | 243.99%69.49M | 247.16%66.57M | 113.57%46.14M | 6.22%22.67M | -3.72%20.2M | -4.83%19.18M | 14.79%21.6M | 12.53%21.34M | 1.41%20.98M | 6.51%20.15M |
Intangible assets | 0.14%227.25M | -2.68%222.28M | 37.38%223.82M | 39.15%225.35M | 147.42%226.93M | 133.02%228.41M | 64.43%162.91M | 60.64%161.95M | -9.16%91.72M | -3.93%98.02M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.66%7.05K | -89.31%7.05K |
Long deferred expense | -7.78%9.84M | -6.56%9.88M | 1.64%10.57M | -2.57%10.82M | 7.23%10.67M | -6.26%10.57M | -14.40%10.4M | -14.20%11.1M | -22.33%9.95M | -13.28%11.28M |
Deferred tax assets | -17.96%14.22M | -13.65%12.81M | 29.12%13.58M | 1.64%10.51M | 32.99%17.33M | -20.84%14.84M | -54.23%10.51M | -39.54%10.34M | -41.86%13.03M | 25.21%18.74M |
Usufruct assets | 105.72%109.58M | 101.99%111.62M | 101.84%115M | 94.64%113.01M | -7.09%53.27M | -38.13%55.26M | -34.08%56.97M | -38.01%58.06M | -26.79%57.33M | 14.02%89.31M |
Other non current assets | 6,980.70%170.8M | 6,886.77%155.78M | 7.24%2.29M | -14.92%2.29M | 7.47%2.41M | -0.66%2.23M | -69.10%2.13M | -60.45%2.69M | 12.08%2.24M | 12.08%2.24M |
Total non current assets | 18.88%3.28B | 19.72%3.23B | 18.32%3.01B | 15.80%2.91B | 26.48%2.76B | 141.32%2.7B | 131.91%2.54B | 130.90%2.51B | 165.36%2.18B | 41.74%1.12B |
Total assets | -7.51%6.26B | 0.74%6.42B | 18.46%7.07B | 22.31%7B | 26.17%6.77B | 19.63%6.38B | 17.30%5.97B | 21.45%5.73B | 22.00%5.37B | 26.63%5.33B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -40.39%1.23B | -20.87%1.4B | 64.46%2.25B | 78.15%2.2B | 80.69%2.06B | 46.05%1.76B | 81.42%1.37B | 88.50%1.23B | 209.79%1.14B | 245.87%1.21B |
Notes payable and accounts payable | -17.65%74.62M | 12.94%84.23M | -27.53%85.03M | 21.00%75.87M | 238.90%90.62M | -85.36%74.59M | -84.96%117.34M | -88.98%62.7M | -96.53%26.74M | 32.86%509.4M |
-Notes payable | -32.10%29.74M | -31.49%29.07M | 17.16%42.92M | 69.79%43.37M | 659.47%43.8M | --42.44M | --36.63M | --25.54M | --5.77M | ---- |
-Accounts payable | -4.14%44.88M | 71.57%55.16M | -47.82%42.11M | -12.54%32.5M | 123.24%46.82M | -93.69%32.15M | -89.66%80.71M | -93.47%37.15M | -97.28%20.97M | 32.86%509.4M |
Contract liabilities | -17.03%73.07M | 17.07%80.7M | -62.03%40.51M | -26.76%50.28M | -44.05%88.07M | -46.66%68.93M | -26.92%106.69M | -13.16%68.65M | 46.60%157.42M | 24.56%129.23M |
Advance receipts | 85.11%2.42M | 40.68%3.5M | -91.66%642.3K | -48.71%3.09M | -75.28%1.31M | -55.52%2.49M | 41.94%7.7M | -14.83%6.02M | -87.58%5.28M | -87.02%5.6M |
Salaries payable | -36.77%4.44M | -53.60%9.18M | -55.58%8.9M | -45.27%27.15M | -24.65%7.01M | -62.77%19.77M | -70.79%20.04M | -57.89%49.61M | -87.73%9.31M | -53.19%53.12M |
Taxs payable | 68.03%11.92M | -54.71%8.4M | 13.20%7.92M | 263.94%14.24M | -12.13%7.09M | -11.03%18.54M | -74.83%6.99M | -89.99%3.91M | -72.08%8.07M | -59.41%20.83M |
Other payable (including interest and dividends) | -20.12%72.58M | 131.44%159.47M | -32.49%46.66M | 7.02%75.51M | 32.69%90.87M | -52.56%68.9M | -46.47%69.12M | -61.86%70.55M | -68.02%68.48M | -67.33%145.26M |
-Dividend payable | 19.29%5.39M | 1,936.54%92.09M | --4.52M | 23.90%4.52M | --4.52M | -77.16%4.52M | ---- | -72.34%3.65M | ---- | -81.41%19.79M |
-Other payable | ---- | 4.66%67.38M | ---- | ---- | ---- | -48.68%64.38M | ---- | -61.06%66.9M | ---- | -62.90%125.46M |
Non current liabilities due within one year | 19.67%49.58M | 39.64%45.08M | 110.96%41.31M | 105.26%40.2M | 341.66%41.43M | 42.77%32.28M | -14.24%19.58M | -12.78%19.58M | -5.01%9.38M | 144.36%22.61M |
Other current liabilities | -24.96%5.88M | 104.81%12.31M | -58.75%3.92M | -27.42%4.28M | -51.91%7.83M | -39.16%6.01M | -15.60%9.49M | 5.60%5.9M | 100.77%16.29M | 21.96%9.88M |
Total current liabilities | -36.40%1.52B | -12.49%1.8B | 44.07%2.49B | 63.64%2.49B | 66.12%2.39B | -2.31%2.05B | -11.28%1.73B | -9.49%1.52B | -11.42%1.44B | 39.64%2.1B |
Current liabilities | ||||||||||
Long term loan | 22.69%628.61M | 28.37%613.63M | 41.14%594.42M | 35.66%538.31M | 191.13%512.37M | 264.68%478.02M | 280.24%421.17M | 605.61%396.8M | 219.64%175.99M | 155.10%131.08M |
Deferred tax liabilities | 0.36%278.93M | 0.36%278.93M | 0.36%278.93M | 0.36%278.93M | 2.99%277.92M | 660.26%277.92M | 621.00%277.92M | 621.00%277.92M | --269.84M | --36.56M |
Long term deferred income | 30.61%554.23M | 8.27%462.76M | -2.98%415.97M | -2.77%418.31M | -2.38%424.35M | -2.22%427.4M | -2.32%428.75M | -2.21%430.22M | -1.08%434.71M | -2.25%437.1M |
Lease liabilities | 108.81%105.92M | 108.44%108.15M | 126.64%112.59M | 100.81%109.82M | -19.28%50.73M | -37.13%51.88M | -39.93%49.68M | -34.74%54.69M | -23.99%62.84M | 2.52%82.53M |
Total non current liabilities | 23.89%1.57B | 18.48%1.46B | 19.06%1.4B | 16.02%1.35B | 34.13%1.27B | 79.73%1.24B | 75.50%1.18B | 87.48%1.16B | 63.45%943.39M | 18.69%687.26M |
Total liabilities | -15.53%3.09B | -0.86%3.26B | 33.93%3.89B | 43.03%3.83B | 53.45%3.65B | 17.90%3.29B | 10.97%2.9B | 16.61%2.68B | 8.22%2.38B | 33.82%2.79B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M | 0.00%583.79M |
Capital reserve funds | 0.00%418.25M | 0.00%418.25M | 0.00%418.25M | 0.00%418.25M | -26.75%418.25M | -26.75%418.25M | -26.75%418.25M | -27.38%418.25M | 0.00%570.96M | 0.00%570.96M |
Surplus reserve funds | 7.09%625.49M | 7.09%625.49M | 7.09%625.49M | 7.09%625.49M | 107.04%584.08M | 107.04%584.08M | 107.04%584.08M | 107.04%584.08M | 105.71%282.1M | 105.71%282.1M |
Retained profit | 0.77%1.48B | 1.89%1.46B | 5.44%1.5B | 6.00%1.48B | -3.96%1.47B | 44.33%1.44B | 52.80%1.42B | 60.57%1.4B | 84.28%1.53B | 32.32%995.95M |
Other composite income | 0.00%29.1M | 0.00%29.1M | 0.00%29.1M | 0.00%29.1M | --29.1M | --29.1M | --29.1M | --29.1M | ---- | ---- |
Shareholders equity without minority interests | 1.71%3.14B | 2.25%3.12B | 3.91%3.15B | 4.16%3.14B | 3.98%3.08B | 25.48%3.05B | 28.26%3.03B | 30.30%3.01B | 39.78%2.97B | 18.99%2.43B |
Minority interests | 19.31%40.34M | 19.77%40.4M | -4.92%31.8M | -3.51%31.71M | 66.59%33.81M | -68.36%33.73M | -69.04%33.45M | -68.43%32.86M | -73.66%20.3M | 34.73%106.61M |
Total shareholder equity | 1.90%3.18B | 2.44%3.16B | 3.81%3.18B | 4.08%3.17B | 4.40%3.12B | 21.54%3.09B | 24.01%3.07B | 26.05%3.05B | 35.81%2.99B | 19.57%2.54B |
Total liabilityies and equity | -7.51%6.26B | 0.74%6.42B | 18.46%7.07B | 22.31%7B | 26.17%6.77B | 19.63%6.38B | 17.30%5.97B | 21.45%5.73B | 22.00%5.37B | 26.63%5.33B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data